Inactive

THIS IS A SOURCES SOUGHT ANNOUNCEMENT ONLY. It is neither a solicitation announcement nor a request for proposals or quotes and does not obligate the Government to award a contract. Requests for a sol... THIS IS A SOURCES SOUGHT ANNOUNCEMENT ONLY. It is neither a solicitation announcement nor a request for proposals or quotes and does not obligate the Government to award a contract. Requests for a solicitation will not receive a response. Responses to this sources sought must be in writing. The purpose of this sources sought announcement is for market research to make appropriate acquisition decisions and to gain knowledge of potential qualified Small Businesses interested and capable of providing the services described below. The information gained from this market research will help the National Institutes (NIH) the Department of Laboratory Medicine plan for its acquisition strategy. Potential Large and Small Businesses shall include business information outlined in the section below as a part of their response. Complete responses to this notice shall be in the following format: SAM UEI Number Company Name Company Address, City, State and Zip Code Company Point of Contact, Email Address and Telephone Number Current GSA Schedule appropriate to this Sources Sought Socioeconomic Status: (i.e., HUBZone, 8a, Small Business, Women Owned Small Business, Veteran-Owned Small-Business, etc.) as validated in Central Contractor Registration (CCR). All offerors must register in CCR located in https://www.sam.gov. Provide a capability statement that addresses the organizations qualifications and ability to perform as a contractor for the work described in the Statement of Work. POTS: 25-000958 ***************************************************************************** The National Institutes of Health, Clinical Center, the Department of Laboratory Medicine has a need for BioFire Defense reagents. The Department of Laboratory own and utilizes BioFire FilmArray analyzers which only compatible with BioFire Defense reagents and test kits. These instruments provide rapid, efficient, and sensitive detection of nucleic acid (DNA) from clinical samples, which allows for timely identification of the presence of infectious agents and hastens treatment. Reagent Descriptions: Product Number: Description RFIT-ASY-0147 Blood Culture Identification Panel 2 IVD, 30 Tests RFIT-ASY-0116-GSA Gastrointestinal Panel IVD, 30 Tests RFIT-ASY-0118-GSA Meningitis/Encephalitis Panel IVD, 30 Tests 423742 Respiratory Panel 2.1 IVD, 30 Tests Period of Performance: Base Period: 01/01/2025-09/30/2025 Option 1: 10/01/2025-09/30/2026 Option 2: 10/01/2026-09/30/2027 Option 3: 10/01/2027-09/30/2028 Option 4: 10/01/2028-09/30/2029 Delivery Schedule: The contractor shall supply reagents on an as need basis. Delivery Location: Deliver to: Attention: TBD National Institutes of Health 10 Center Drive Building 10, Room TBD Bethesda, MD 20892-1288 Contractors shall not reach out to the customer for any questions or clarifications. All communications must go through contracting. ****************************************************************************** Important information: The Government is not obligated to nor will it pay for or reimburse any costs associated with responding to this source sought synopsis request. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No sub-contracting opportunity is anticipated. NAICS: 325413- In-Vitro Diagnostic Substance Manufacturing-Small Business Size Standards 1,250 Average Number of Employees. PSC: 6550- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets Notice to potential offerors: All offerors who provide goods or services to the United States Federal Government must be registered and have an active registration in the System for Award Management (SAM) at www.sam.gov and complete Online Representations and Certifications Application (ORCA). All interested Offerors should submit information by e-mail to sheri.eiri@nih.gov All information submissions shall be received no later than 12:00 pm Eastern Standard Time, November 07, 2024.